The development of carboranes as new agents in the diagnosis and treatment of brain disease

碳硼烷作为诊断和治疗脑疾病的新药物的开发

• 批准号: DP110104237
• 负责人: Prof Michael Kassiou
• 金额: $ 29.56万
• 依托单位: The University of Sydney
• 依托单位国家: 澳大利亚
• 项目类别: Discovery Projects
• 财政年份: 2011
• 资助国家: 澳大利亚
• 起止时间: 2011-03-28 至 2015-03-27
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/DP110104237
• 关键词: development; carboranes; new; agents; diagnosis

The treatment of brain diseases is one of society's major challenges. To address these challenges, we need a better understanding of the molecular mechanisms involved in brain disease. This project will develop innovative agents to probe disease progression, assess efficacy of treatment, and ultimately treat a wide range of brain disorders.

脑部疾病的治疗是社会的主要挑战之一。为了应对这些挑战，我们需要更好地了解脑部疾病所涉及的分子机制。该项目将开发创新的药物来探测疾病进展，评估治疗的功效，并最终治疗多种脑部疾病。